SciELO - Scientific Electronic Library Online

 
vol.30 número2Evaluación de la eficiencia técnica de la atención primaria pública en el País Vasco, 2010-2013Análisis de las barreras y oportunidades legales-éticas de la comunicación y disculpa de errores asistenciales en España índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Gaceta Sanitaria

versión impresa ISSN 0213-9111

Resumen

MATTOZO ROVER, Marina Raijche; VARGAS-PELAEZ, Claudia Marcela; ROCHA FARIAS, Mareni  y  NAIR LEITE, Silvana. Access to high-cost drugs in Brazil from the perspective of physicians, pharmacists and patients. Gac Sanit [online]. 2016, vol.30, n.2, pp.110-116. ISSN 0213-9111.  http://dx.doi.org/10.1016/j.gaceta.2015.12.005.

Objective: To explore perceptions on access to medication supplied by the Specialized Component of Pharmaceutical Assistance (CEAF) within the Brazilian Unified Health System (which includes high-cost drugs) by the actors involved in the healthcare services of this component. Method: A descriptive, qualitative study was carried out by using a focal group with 7 users and 11 semi-structured interviews with health professionals (physicians and pharmacist) in the state of Santa Catarina. Results: According to the participants, access to medicines had improved. Two main perceptions of the CEAF Clinical Guidelines were identified: the requirements constitute a bureaucracy that limits access, and the requisites increase the demand for tests and specialized healthcare services, exceeding the capacity of the healthcare services network. These assumptions generated the search for other means of access that revealed a lack of information and understanding of the right to health among the users. In addition, according to the participants, because of the difficulties of accessing services as a whole, full access to CEAF medicines is a goal that remains to be achieved. Conclusion: Although access to CEAF medicines has improved, there are still some difficulties in guaranteeing treatment access and comprehensiveness.

Palabras clave : Pharmaceutical services; Health services accessibility; Clinical practice guidelines as topic; Drugs, essential; Technology, high-cost; Brazil.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons